Lipaxan and liver disorder Patient Reports February 10, 2012

Lipaxan Side Effects Report #5463986-2
Lipaxan side effect was reported by a Consumer or non-health professional from ITALY on Sept 17, 2007. Female patient, 68 years of age, was diagnosed with dyslipidaemia and was treated with Lipaxan. After drug was administered, patient experienced the following side effects: aphonia, biliary tract disorder, blood creatine phosphokinase increased, dyspnoea, liver disorder, myalgia, myoglobin blood increased, rhabdomyolysis. Lipaxan dosage: 80 MG, UNK. During the same period patient was treated with PAROXETINE. Patient died on 09/13/2007.

Lipaxan Side Effects Report #5467254-4
Lipaxan side effect was reported by a Consumer or non-health professional from ITALY on Sept 18, 2007. Female patient, 68 years of age, was diagnosed with dyslipidaemia and was treated with Lipaxan. After drug was administered, patient experienced the following side effects: aphonia, biliary tract disorder, blood creatine phosphokinase increased, chromaturia, dyspnoea, liver disorder, myalgia, myoglobin blood increased, rhabdomyolysis. Lipaxan dosage: 80 MG, UNK. During the same period patient was treated with PAROXETINE. Patient died on 09/13/2007.

Lipaxan Side Effects Report #5474049-4
Lipaxan side effect was reported by a Consumer or non-health professional from ITALY on Sept 26, 2007. Female patient, 68 years of age, was diagnosed with dyslipidaemia and was treated with Lipaxan. After drug was administered, patient experienced the following side effects: aphonia, biliary tract disorder, blood creatine phosphokinase increased, chromaturia, dyspnoea, liver disorder, myalgia, myoglobin blood increased, rhabdomyolysis. Lipaxan dosage: 80 MG/D. During the same period patient was treated with PAROXETINE. Patient died on 09/13/2007.